SCHEMBL18308792

SCHEMBL18308792

Cc1ccc(-c2ccc(C)c(-c3ccc(P)cc3)c2)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HPRT1 P00492 1/20 0.38
▸ MCL1 Q07820 1/20 0.34
▸ RXRA P19793 2/20 0.34
▸ RARA P10276 1/20 0.34
▸ MAP4K4 O95819 1/20 0.33
▸ LRRK2 Q5S007 1/20 0.33
▸ ESRRA P11474 1/20 0.33
▸ MAPK14 Q16539 1/20 0.33
▸ ALKBH3 Q96Q83 2/20 0.33
▸ ADORA3 P0DMS8 1/20 0.33
▸ PTGS2 P35354 1/20 0.33
▸ ACHE P22303 1/20 0.32
▸ TDP1 Q9NUW8 1/20 0.32
▸ MAPT P10636 1/20 0.32
▸ RARB P10826 1/20 0.32
▸ RARG P13631 1/20 0.32
▸ CA12 O43570 1/20 0.32
▸ CA9 Q16790 1/20 0.32
▸ PDK2 Q15119 1/20 0.32
▸ MEN1 O00255 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18308781 1.00 HPRT1 (0.38) HPRT1MCL1RXRARARAMAP4K4
SCHEMBL18436840 0.94 RXRA (0.36) HPRT1RXRARARAMAPK14TDP1
SCHEMBL15435579 0.88 ESRRA (0.41) ESRRAADORA3TDP1MAPTMEN1
SCHEMBL18308763 0.84 ESR2 (0.37) HPRT1MCL1ALKBH3ADORA3PTGS2
SCHEMBL18308786 0.84 ESR2 (0.37) HPRT1MCL1ALKBH3ADORA3PTGS2
SCHEMBL18308780 0.82 RXRA (0.31) RXRARARAMAPK14
SCHEMBL18308784 0.82 RXRA (0.31) RXRARARAMAPK14
SCHEMBL10452705 0.80 NPSR1 (0.41) MAP4K4ALKBH3PTGS2
SCHEMBL1687651 0.80 ACHE (0.50) MCL1ACHETDP1CA9
SCHEMBL12991138 0.80 ACHE (0.50) MCL1ACHETDP1CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11718791-B2 Polymerisable compounds and the use thereof in liquid-crystal displays MERCK PATENT GMBH (DE) 2023-08-08 — — US disclosed
US-20170121606-A1 POLYMERIZABLE COMPOUNDS AND THE USE THEREOF IN LIQUID-CRYSTAL DISPLAYS GMBH, MERCK PATENT (DE) 2017-05-04 — — US disclosed
US-20160362606-A1 POLYMERIZABLE COMPOUNDS AND THE USE THEREOF IN LIQUID-CRYSTAL DISPLAYS MERCK PATENT GMBH (DE) 2016-12-15 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11718791-B2 Polymerisable compounds and the use thereof in liquid-crystal displays VCL, ILK, LCP1 HPRT1 2805/4885MCL1 1595/4885RXRA 2691/4885
US-20170121606-A1 POLYMERIZABLE COMPOUNDS AND THE USE THEREOF IN LIQUID-CRYSTAL DISPLAYS VCL, LCP1, MAP1LC3C HPRT1 2846/4885MCL1 1419/4885RXRA 1974/4885
US-20160362606-A1 POLYMERIZABLE COMPOUNDS AND THE USE THEREOF IN LIQUID-CRYSTAL DISPLAYS VCL, PLEC, EML4 HPRT1 2657/4885MCL1 3415/4885RXRA 2009/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback